Bronchiectasis / Test explainer
Bronchiectasis tests - what we are looking for
The baseline aetiology bundle, in two versions: the list for the request form and the explanation for the patient.
Baseline investigation of newly diagnosed bronchiectasis. Everyone: Full blood count with differential white cell count Serum immunoglobulins G, A and M Serum electrophoresis Total IgE, and specific IgE or skin prick testing to Aspergillus fumigatus Aspergillus IgG (precipitins) Sputum culture for bacteria, including specific request for Pseudomonas Sputum culture for mycobacteria, including non-tuberculous mycobacteria Sputum for fungal culture CRP Spirometry with reversibility Guided by the history and the pattern on CT: Specific antibody responses to pneumococcal capsular polysaccharide, with post-immunisation levels if baseline is low Rheumatoid factor, anti-CCP antibodies, ANA and ANCA Alpha-1 antitrypsin level Cystic fibrosis testing: sweat test and CFTR genetics Testing for primary ciliary dyskinesia: nasal nitric oxide, then referral to a diagnostic centre HIV testing Assessment of aspiration and reflux Bronchoscopy if the disease is focal, to exclude an obstructing lesion Findings so far: [] Cause identified: [], or no cause identified after full assessment.
Variants
For the patient
The same bundle, written to go into the clinic letter so that someone handed six blood forms knows what each one is for.
About the tests we have arranged Bronchiectasis is a description of what your airways look like, not a cause in itself. Something damaged them, and in around half of people we can find out what. It is worth looking, because a few of the causes have specific treatments, and finding one can change what we do next. The blood tests look for: - problems with the immune system, particularly low levels of antibodies, which can be treated with replacement antibody - an allergic reaction to a common mould called aspergillus, which is treated with steroids and antifungal medicine - conditions such as rheumatoid arthritis, which are associated with bronchiectasis - inherited conditions, including cystic fibrosis and a protein deficiency called alpha-1 antitrypsin deficiency. The sputum tests look for the bacteria living in your airways, so that if you need antibiotics we can choose one that will work. We also test specifically for a group of bacteria related to tuberculosis, called non-tuberculous mycobacteria. These are common in soil and water and are usually harmless, but they can settle in damaged airways, and if they are present they change which treatments are safe to use. This test is slow: the bacteria grow very slowly in the laboratory, and it can take up to eight weeks for a final result. The breathing tests measure how much your airways are affected, and give us a number to compare with in future. In many people, no single cause is ever found. That is a common result rather than a failure of the tests, and it does not change how well the condition can be managed.
How to use it
Angshu's original bronchiectasis block ended with a note hoping someone would improve it, so this is that attempt: the management advice is now its own patient-facing block, and this one covers the investigation the guidelines put at the front of the pathway. The everyone list is the minimum bundle recommended for every newly diagnosed adult; the second list is what a history or a CT pattern should prompt. Two practical points earn their place in the patient version — that a cause is found in only about half of people, and that mycobacterial cultures take weeks — because both otherwise generate an anxious phone call.
Why it says that
None of this is in the copied text. It is here so you can check the block against its source, and change it when the source changes.
- BTS guideline for bronchiectasis in adults (2019) The baseline aetiological bundle for all adults with a new diagnosis, including total serum immunoglobulins, and the further tests to be directed by clinical features.
- ERS clinical practice guideline for the management of adult bronchiectasis (2025) Standardised testing to identify treatable causes, specifically immunodeficiency, allergic bronchopulmonary aspergillosis, non-tuberculous mycobacterial infection and cystic fibrosis.
- BTS guideline for the management of non-tuberculous mycobacterial pulmonary disease Why the mycobacterial culture is not optional before long-term macrolide treatment is started.